The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Evaluating Second-Line Treatment Options in Bladder Cancer

Daniel P. Petrylak, MD
Published Online:6:16 PM, Fri December 16, 2016

Daniel P. Petrylak, MD, professor of Medicine and Urology, Yale Cancer Center, discusses studies evaluating second-line treatment options in bladder cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.